Study highlights opportunity for treatment intensification in this population since approximately 50 percent of patients with high-risk localised prostate.
Johnson & Johnson announced today that new clinical and real-world data will be presented via 18 abstracts at the ASCO GU symposium being held January 25-27 in San Francisco, underlining the company s.
/PRNewswire/ Johnson & Johnson announced today new clinical and real-world evidence data will be featured in 18 abstracts at this year s ASCO GU Symposium.